Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Will

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 9, 2008
Statistical methods for building random transposon mutagenesis librariesOliver Will
Nature|April 19, 2002
Using the fossil record to estimate the age of the last common ancestor of extant primatesSimon Tavaré, Charles R Marshall, Oliver Will, et al.
The Patient|March 16, 2024
A Novel Approach to Computing Preference Estimates for Different Treatment Pathways: An Application in OncologyKathleen Beusterien, Oliver Will, Emuella Flood, et al.
Current Medical Research and Opinion|June 15, 2021
Patient and neurologist preferences in the UK for relapsing-remitting multiple sclerosis treatments: findings from a discrete choice experimentTom Tencer, Oliver Will, Jinender Kumar, et al.
Patient Preference and Adherence|November 12, 2020
Oncologist and Patient Preferences for Attributes of CDK4/6 Inhibitor Regimens for the Treatment of Advanced/Metastatic HR Positive/HER2 Negative Breast Cancer: Discrete Choice Experiment and Best-Worst ScalingMartine C Maculaitis, Xianchen Liu, Oliver Will, et al.
Patient Preference and Adherence|July 16, 2021
Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice ExperimentJinender Kumar, M Janelle Cambron-Mellott, Tom Tencer, et al.
Future Oncology (London, England)|June 16, 2025
Patient preferences for treatment pathways in early-stage breast cancer: application of a discrete choice experimentChristian Jackisch, Chikako Shimizu, Emuella Flood, et al.
Patient Preference and Adherence|September 14, 2023
Patient Preferences for Adjuvant Treatment in Muscle-Invasive Urothelial Carcinoma: A Multi-Country Discrete Choice ExperimentKristen King-Concialdi, Kathleen Beusterien, Steven S Senglaub, et al.
Patient Preference and Adherence|October 18, 2023
Prioritizing Treatment Goals of People Diagnosed with Bipolar I Disorder in the US: Best-Worst Scaling ResultsJohn F P Bridges, Joseph F Goldberg, Heather M Fitzgerald, et al.
Human Vaccines & Immunotherapeutics|January 25, 2019
Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United StatesJohn M McLaughlin, David L Swerdlow, Farid Khan, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|April 9, 2008
Statistical methods for building random transposon mutagenesis librariesOliver Will
Nature|April 19, 2002
Using the fossil record to estimate the age of the last common ancestor of extant primatesSimon Tavaré, Charles R Marshall, Oliver Will, et al.
The Patient|March 16, 2024
A Novel Approach to Computing Preference Estimates for Different Treatment Pathways: An Application in OncologyKathleen Beusterien, Oliver Will, Emuella Flood, et al.
Current Medical Research and Opinion|June 15, 2021
Patient and neurologist preferences in the UK for relapsing-remitting multiple sclerosis treatments: findings from a discrete choice experimentTom Tencer, Oliver Will, Jinender Kumar, et al.
Patient Preference and Adherence|November 12, 2020
Oncologist and Patient Preferences for Attributes of CDK4/6 Inhibitor Regimens for the Treatment of Advanced/Metastatic HR Positive/HER2 Negative Breast Cancer: Discrete Choice Experiment and Best-Worst ScalingMartine C Maculaitis, Xianchen Liu, Oliver Will, et al.
Patient Preference and Adherence|July 16, 2021
Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice ExperimentJinender Kumar, M Janelle Cambron-Mellott, Tom Tencer, et al.
Future Oncology (London, England)|June 16, 2025
Patient preferences for treatment pathways in early-stage breast cancer: application of a discrete choice experimentChristian Jackisch, Chikako Shimizu, Emuella Flood, et al.
Patient Preference and Adherence|September 14, 2023
Patient Preferences for Adjuvant Treatment in Muscle-Invasive Urothelial Carcinoma: A Multi-Country Discrete Choice ExperimentKristen King-Concialdi, Kathleen Beusterien, Steven S Senglaub, et al.
Patient Preference and Adherence|October 18, 2023
Prioritizing Treatment Goals of People Diagnosed with Bipolar I Disorder in the US: Best-Worst Scaling ResultsJohn F P Bridges, Joseph F Goldberg, Heather M Fitzgerald, et al.
Human Vaccines & Immunotherapeutics|January 25, 2019
Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United StatesJohn M McLaughlin, David L Swerdlow, Farid Khan, et al.
Pageof 2